Policy & Recommendations
EU Global Health Strategy to improve global health security and deliver better health for all
On 30 November, The European Commission adopted Europe’s agenda for global health action for the next 10 years.
Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities
Biotherapeutics, such as recombinant proteins and monoclonal antibodies, have become mainstays of modern medicine as shown by their increasing number in the WHO Model List of Essential Medicines.
ESWI Summit 2022: expert panel view – Mark Eccleston-Turner
ESWI Summit 2022: Expert panel view – Lwazi Manzi
ESWI Summit 2022 – Stakeholder Debate